A Food Effect Study of TAK-385 Final Formulation
NCT02792062
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Japanese Premenopausal Healthy Adult Women
Interventions
DRUG:
TAK-385 40 mg
Sponsor
Takeda